ArticleJournal of clinical medicine2020

Extent of Mucosal Inflammation in Ulcerative Colitis Influences the Clinical Remission Induced by Vedolizumab.

Patrizio Scarozza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.